Abstract
Observations made in a controlled double-blind investigation of two non-halogenated topical steroids, hydrocortisone-17-butyrate (HCB) and budesonide in thirty-six patients with psoriasis revealed a clear difference in therapeutic effect between the two ointments, indicating that they belong to different groups of topical steroids according to a classification accepted in the Nordic countries. Budesonide had a good therapeutic effect in all the patients studied, while, as a rule, HCB was clearly less effective.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
MeSH terms
-
Administration, Topical
-
Anti-Inflammatory Agents / therapeutic use*
-
Budesonide
-
Clinical Trials as Topic
-
Dermatologic Agents / administration & dosage*
-
Double-Blind Method
-
Female
-
Glucocorticoids / administration & dosage*
-
Humans
-
Hydrocortisone / administration & dosage
-
Hydrocortisone / analogs & derivatives*
-
Male
-
Middle Aged
-
Ointments
-
Pregnenediones / administration & dosage*
-
Psoriasis / drug therapy
Substances
-
Anti-Inflammatory Agents
-
Dermatologic Agents
-
Glucocorticoids
-
Ointments
-
Pregnenediones
-
hydrocortisone-17-butyrate
-
Budesonide
-
Hydrocortisone